Phase I trial of MetaMx in patients with malignant glioma
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2016
At a glance
- Drugs MetaMx (Primary)
- Indications Glioma
- Focus Adverse reactions
- Sponsors Arch Biopartners
- 03 Feb 2016 According to an Arch Biopartners media release, this trial is expected to start by late 2016.
- 09 Dec 2014 New trial record
- 26 Nov 2014 Upon completion of a pre-IND meeting, it is planned to move ahead with the filing of the IND application and execution of this MetaMx Phase I trial at a single centre in the US, according to an Arch Biopartners media release.